CNX vs. CERE, HCC, ARCH, HNRG, MRO, OVV, PR, CHK, APA, and AR
Should you be buying CNX Resources stock or one of its competitors? The main competitors of CNX Resources include Cerevel Therapeutics (CERE), Warrior Met Coal (HCC), Arch Resources (ARCH), Hallador Energy (HNRG), Marathon Oil (MRO), Ovintiv (OVV), Permian Resources (PR), Chesapeake Energy (CHK), APA (APA), and Antero Resources (AR).
Cerevel Therapeutics (NASDAQ:CERE) and CNX Resources (NYSE:CNX) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings, community ranking and dividends.
87.7% of Cerevel Therapeutics shares are held by institutional investors. Comparatively, 95.2% of CNX Resources shares are held by institutional investors. 5.1% of Cerevel Therapeutics shares are held by insiders. Comparatively, 4.7% of CNX Resources shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Cerevel Therapeutics currently has a consensus price target of $42.67, suggesting a potential upside of 3.81%. CNX Resources has a consensus price target of $25.00, suggesting a potential downside of 1.07%. Given CNX Resources' stronger consensus rating and higher probable upside, equities research analysts plainly believe Cerevel Therapeutics is more favorable than CNX Resources.
CNX Resources received 661 more outperform votes than Cerevel Therapeutics when rated by MarketBeat users. Likewise, 70.59% of users gave CNX Resources an outperform vote while only 66.52% of users gave Cerevel Therapeutics an outperform vote.
Cerevel Therapeutics has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. Comparatively, CNX Resources has a beta of 1.36, suggesting that its stock price is 36% more volatile than the S&P 500.
CNX Resources has a net margin of 40.44% compared to CNX Resources' net margin of 0.00%. Cerevel Therapeutics' return on equity of 7.68% beat CNX Resources' return on equity.
In the previous week, Cerevel Therapeutics and Cerevel Therapeutics both had 4 articles in the media. CNX Resources' average media sentiment score of 1.13 beat Cerevel Therapeutics' score of 0.69 indicating that Cerevel Therapeutics is being referred to more favorably in the media.
CNX Resources has higher revenue and earnings than Cerevel Therapeutics.
Summary
CNX Resources beats Cerevel Therapeutics on 8 of the 13 factors compared between the two stocks.
Get CNX Resources News Delivered to You Automatically
Sign up to receive the latest news and ratings for CNX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CNX Resources Competitors List
Related Companies and Tools
